Literature DB >> 19661690

HSP40 ameliorates impairment of insulin secretion by inhibiting huntingtin aggregation in a HD pancreatic beta cell model.

Cui-Fang Ye1, He Li.   

Abstract

Diabetes frequently develops in Huntington's disease patients. Here, we found that mutant huntingtin forms aggregates in the cytoplasm and reduces insulin secretion from huntingtin transfected pancreatic beta cell lines, NIT-1 cells. Activity of the pro-survival factor, Akt, is enhanced in these cells, which might improve the maintenance of insulin content. Overexpression of heat shock protein 40 (HSP40) inhibits aggregation, reverses impaired insulin release, and blocks the enhancement of Akt activity. These results suggest that impairment of beta cells is mostly linked with the aggregate formation of mutant huntingtin, and that HSP40 ameliorates the malfunction of pancreatic beta cells by inhibiting aggregation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661690     DOI: 10.1271/bbb.90147

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  HAP1 helps to regulate actin-based transport of insulin-containing granules in pancreatic β cells.

Authors:  Zhiyong Wang; Ting Peng; Hongnian Wu; Jun He; He Li
Journal:  Histochem Cell Biol       Date:  2015-03-06       Impact factor: 4.304

2.  Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by Huntingtin-associated Protein 1.

Authors:  Jing-Ying Pan; Shijin Yuan; Tao Yu; Cong-Lin Su; Xiao-Long Liu; Jun He; He Li
Journal:  J Biol Chem       Date:  2016-09-13       Impact factor: 5.157

3.  Mutant Huntingtin Impairs Pancreatic β-cells by Recruiting IRS-2 and Disturbing the PI3K/AKT/FoxO1 Signaling Pathway in Huntington's Disease.

Authors:  Li Li; Yun Sun; Yinong Zhang; Weixi Wang; Cuifang Ye
Journal:  J Mol Neurosci       Date:  2021-07-31       Impact factor: 3.444

4.  DNAJB3/HSP-40 cochaperone is downregulated in obese humans and is restored by physical exercise.

Authors:  Jehad Abubaker; Ali Tiss; Mohamed Abu-Farha; Fahad Al-Ghimlas; Irina Al-Khairi; Engin Baturcam; Preethi Cherian; Naser Elkum; Maha Hammad; Jeena John; Sina Kavalakatt; Abdelkrim Khadir; Samia Warsame; Said Dermime; Kazem Behbehani; Mohammed Dehbi
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.